Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1974-4-4
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0012-0472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
18
|
pubmed:volume |
99
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
112-3
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:4812781-Arterial Occlusive Diseases,
pubmed-meshheading:4812781-Enzymes,
pubmed-meshheading:4812781-Fibrinolytic Agents,
pubmed-meshheading:4812781-Hemolysin Proteins,
pubmed-meshheading:4812781-Humans,
pubmed-meshheading:4812781-Injections, Subcutaneous,
pubmed-meshheading:4812781-Venoms
|
pubmed:year |
1974
|
pubmed:articleTitle |
[Letter: Therapeutic defibrination with Ancrod].
|
pubmed:publicationType |
Journal Article
|